Mitsui Chemicals (4183) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
28 May, 2026Business performance and financial outlook
Specialty chemicals domains drove profit growth in FY25, while Basic & Green Materials (B&GM) remained negative due to low operating rates and inventory losses; steady profit growth is expected in FY26 despite geopolitical risks.
FY25 sales revenue was ¥1,669bn with operating income before special items at ¥100bn; FY26 outlook projects sales revenue of ¥1,900bn and operating income before special items of ¥105bn.
Net income attributable to owners is forecast to rise 31% to ¥45bn in FY26.
Specialty chemicals domains are the main earnings driver, but capital efficiency is challenged by deficits and impairment losses in B&GM.
ROE and ROIC are targeted to improve to 13% and 9% or more, respectively, by FY30.
Cash flow, capital policy, and shareholder returns
Operating cash flow is improving through profit growth in specialty chemicals and an asset-light approach, enabling proactive investments and enhanced shareholder returns.
FY25 saw a ¥30bn share repurchase and plans to cancel 20 million treasury shares by August FY26.
Dividend policy aims for stable, continuous returns with a target total return ratio of 40% or more and DOE of 3%+, considering enhancement to 4% by FY28.
Business portfolio transformation and sustainability
Accelerating transformation with a focus on certified products (Blue Value™ and Rose Value™), aiming for 40% sales revenue ratio from these by FY30.
Expanding social issue-driven product lines and increasing gross profit from certified products.
Strategic investments and M&A target growth in specialty domains, especially L&HC and ICT, while restructuring underperforming businesses.
Strengthening green chemicals and recycling initiatives, including bio-based and chemically recycled products, and partnerships for circularity.
Latest events from Mitsui Chemicals
- FY 2026 profit is set to rise on specialty chemicals growth and restructuring, despite external risks.4183
Q4 202618 May 2026 - Profits fell on Basic & Green Materials weakness, but ICT Solutions and capital returns remain strong.4183
Q3 202616 Feb 2026 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 20253 Feb 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 20252 Feb 2026 - H1 FY2024 profit surged 26% YoY; full-year growth expected despite plant and input cost issues.4183
Q2 202516 Jan 2026 - Profits rose on Specialty Chemicals and Mobility Solutions, offsetting Basic & Green Materials losses.4183
Q3 20259 Jan 2026 - Profits fell on restructuring and impairment losses, but specialty chemicals remained resilient.4183
Q1 202623 Nov 2025 - Specialty chemicals strength offsets profit decline; FY2025 outlook and stock split announced.4183
Q2 202621 Nov 2025